Want to see AHCO full AI Analyst Report?
AHCO Stock Chart & Stats
$5.48
$0.29(2.77%)
At close: 4:00 PM EDT
$5.48
$0.29(2.77%)
Day’s Range― - ―
52-Week Range$5.21 - $13.43
Previous Close$10.7
Volume821.52K
Average Volume (3M)3.89M
Market Cap
$797.61M
Enterprise Value$3.45K
Total Cash (Recent Filing)$43.29M
Total Debt (Recent Filing)$2.07B
Price to Earnings (P/E)―
Beta-0.10
Next Earnings
Nov 10, 2026EPS Estimate
-0.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.68
Shares Outstanding136,344,200
10 Day Avg. Volume2,496,062
30 Day Avg. Volume3,890,432
Financial Highlights & Ratios
PEG Ratio0.10
Price to Book (P/B)0.89
Price to Sales (P/S)0.41
P/FCF Ratio6.14
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$10.20Price Target Upside86.13% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
EPS Forecast (FY)-0.02
Revenue Forecast (FY)$2.88B
Bulls Say, Bears Say
Bulls Say
Broad-Based Core Segment GrowthGrowth across Sleep, Respiratory, and Wellness-at-Home indicates that expansion is not dependent on a single product line. Broad-based demand for home-based therapies and supplies can support durable revenue growth, improve operating scale, and reinforce AdaptHealth’s position with referral partners.
Expanding Capitated Revenue PlatformRapid capitated revenue growth and the large Humana member transition expand AdaptHealth’s contracted patient base and geographic reach. Over time, these agreements can create recurring healthcare revenue, deepen payer relationships, and provide a platform for greater scale in home-based care.
Resilient Operating Cash GenerationStrong operating cash flow despite reported net losses demonstrates that the core business continues to convert patient services and equipment activity into cash. This supports ongoing investment, debt reduction, and the ability to manage temporary working-capital or restructuring pressures.
Bears Say
Severe Profitability And Margin CompressionThe sharp decline in gross margin and return to a sizable net loss weaken the economics of AdaptHealth’s revenue base. Persistently lower profitability reduces internal funding capacity, limits the benefit of topline growth, and makes earnings more sensitive to reimbursement and operating-cost changes.
Elevated Leverage And Reduced FlexibilityAbove-average leverage combined with negative returns leaves less financial flexibility if earnings remain under pressure. Debt obligations can constrain capital allocation, increase the importance of consistent cash generation, and make future operating setbacks more consequential for the balance sheet.
Supplier Contract Cost PressureThe supplier termination and immediate price increase create a direct and potentially persistent margin headwind. Unless negotiations or alternative purchasing arrangements offset the impact, higher product costs can reduce profitability across equipment and supplies and undermine the benefits of revenue growth.
AdaptHealth News
AHCO FAQ
What was AdaptHealth’s price range in the past 12 months?
AdaptHealth lowest stock price was $5.21 and its highest was $13.43 in the past 12 months.
What is AdaptHealth’s market cap?
AdaptHealth’s market cap is $797.61M.
When is AdaptHealth’s upcoming earnings report date?
AdaptHealth’s upcoming earnings report date is Nov 10, 2026 which is in 59 days.
How were AdaptHealth’s earnings last quarter?
AdaptHealth released its earnings results on Aug 04, 2026. The company reported $0.16 earnings per share for the quarter, missing the consensus estimate of $0.169 by -$0.009.
Is AdaptHealth overvalued?
According to Wall Street analysts AdaptHealth’s price is currently Undervalued.
Does AdaptHealth pay dividends?
AdaptHealth does not currently pay dividends.
What is AdaptHealth’s EPS estimate?
AdaptHealth’s EPS estimate is -0.05.
How many shares outstanding does AdaptHealth have?
AdaptHealth has 136,344,200 shares outstanding.
What happened to AdaptHealth’s price movement after its last earnings report?
AdaptHealth reported an EPS of $0.16 in its last earnings report, missing expectations of $0.169. Following the earnings report the stock price went down -38.042%.
Which hedge fund is a major shareholder of AdaptHealth?
Currently, no hedge funds are holding shares in AHCO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
AdaptHealth Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$10.20 (86.13% Upside)
$10.20 (86.13% Upside)
Blogger Sentiment
Bullish
AHCO Sentiment 100%
Sector Average 62%
Sector Average 62%
Hedge Fund Trend
Increased
By 69.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $394.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.8%
Last 30 Days ▲ 6.3%
Last 30 Days ▲ 6.3%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-36.41%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-0.23%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
AdaptHealth
AdaptHealth Corp., alongside its network of subsidiaries, delivers a comprehensive range of home medical equipment (HME), supplies, and associated services across the United States. The company specializes in sleep therapy, providing CPAP and bi-PAP devices and support for individuals managing obstructive sleep apnea. It also furnishes essential medical devices and provisions for diabetes treatment, such as continuous glucose monitors and insulin pumps. AdaptHealth supplies HME to patients transitioning from acute care settings, offers in-home oxygen and chronic therapy services, and caters to chronically ill patients with specialized equipment and supplies for wound care, urological, incontinence, ostomy, and nutritional needs. These services are accessible to beneficiaries of Medicare, Medicaid, and various commercial insurance payors. AdaptHealth Corp. is primarily based in Plymouth Meeting, Pennsylvania.
AHCO Company Deck
AHCO Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presents a mixed picture: underlying top-line growth and strong segment performance (double-digit organic growth, expanding capitated revenue, digital adoption, strategic portfolio simplification and actions to reduce debt) are meaningful positives. However, material near-term headwinds — notably operational inefficiencies and elevated costs on a large West Coast capitated contract, an unexpected supplier price increase ($30M H2 impact), a significant reduction in full-year adjusted EBITDA guidance, a Q2 negative free cash flow driven by elevated CapEx, and a $144.2M goodwill impairment — temper the outlook. Management outlined concrete remediation steps (workflow fixes, technology/digital adoption, restructuring savings, debt paydown plans and expected elimination of stranded overhead) and expects sequential improvement toward run-rate profitability, but the magnitude of the near-term earnings and cash-flow impacts means the positives and negatives are largely in balance for the near term.View all AHCO earnings summariesAHCO Stock 12 Month Forecast
Average Price Target
$10.20
▲(86.13% Upside)
Technical Analysis
Ownership Overview
15.14% Insiders
23.27% Mutual Funds
28.84% Other Institutional Investors
8.47% Public Companies and
Individual Investors